This study aims to verify whether the moisture of 400 µg of misoprostol pre uterine evacuation increases the dilatation of uterine cervix compared to dry misoprostol
Misoprostol is the most widely used drug for abortion due to its low cost, stability and easy to use regimen. Nevertheless, there is a debate whether the administration of dry misoprostol has similar effects compared to wet pill. It would be necessary to undertake a clinical trial to evaluate which regimen (dry or wet) offers a better cervical dilation pre uterine evacuation. The primary objective of this study is to compare the degree of cervical dilatation pre-uterine evacuation in subject that received 400 µg of dry or wet misoprostol 3 or more hours before the procedure. Secondary objective is to verify whether there is a correlation between vaginal pH (\<5 / ≥5) and the degree of cervical dilation (≥8mm / \<8mm) with the use of wet or dry misoprostol. Women will be randomized to one of the two groups: dry or wet misoprostol.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
46
400 µg of dry misoprostol will be introduced into the vaginal fornices 3 or more hours before uterine evacuation
400 µg of wet misoprostol will be introduced into the vaginal fornices 3 or more hours before uterine evacuation
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Cervical dilation
Cervical dilation will be measure with Karman cannulas
Time frame: 3 to 4 hours after putting misoprostol into the vagina
Vaginal acidity - hydrogen ion concentration
at the moment of the introduction of misoprostol into the vagina
Time frame: within 2 min before putting the misoprostol into the vagina
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.